Market Snapshot
  • BSE Sensex: 77414.92 -0.25%
  • BSE 500: 33579.22 -0.39%
  • BSE 200: 10603.5 -0.39%
  • BSE 100: 24577.8 -0.38%
  • BSE MidCap: 41531.12 -0.68%
  • BSE SmallCap: 46638.13 -0.35%
  • BSE BANKEX: 59542.38 0.36%
  • BSE IT: 36122.71 -1.77%
  • Nifty 50: 23519.35 -0.31%
  • Nifty 500: 21339.55 -0.32%
  • Nifty 200: 12982.75 -0.36%
  • Nifty 100: 24057.35 -0.36%
  • Nifty Midcap 100: 51672.25 -0.32%
  • Nifty Small 100: 16095.7 -0.15%
  • Nifty IT: 36886.15 -1.76%
  • Nifty PSU Bank: 6263.4 -0.52%
News:
  • SPARC submits application for ...
  • Tera Software bags order worth...
  • Arrow Greentech secures US pat...
  • Newgen Software Tech secures R...
  • HBL Engineering secures five K...
  • Euro to INR:  92.47 0.09%
  • Pound to INR:  110.90 0.24%
  • Yen to INR:  0.57 -0.18%
  • Dollar to INR:  85.76 0.04%
My Portfolio:
  • 0.00 0

Quotes

Back To Menu

Parmax Pharma Ltd Share Price – BSE

Pharmaceuticals, Small Cap

Invest

28 Mar 2025 | 03:59 PM

42.24
0.83 (2.00%)

  • Outperforms Index

    48.31%

    Return (1Y)

    Beaten BSE Sensex by 43.2%

  • More Volatile

    4.15%

    Standard Deviation (1Y)

    Higher than BSE Sensex by 3.27%

  • Consistent Performer

    7/12

    Months

    beaten BSE Sensex

  • AxisDirect View

    No View

52 Week High-Low

54

54.00

25

25.03

News & Announcements

  • Parmax Pharma reports standalone net loss of Rs 0.39 crore in the December 2024 quarter

    44 days ago

  • Parmax Pharma to conduct board meeting

    52 days ago

  • Parmax Pharma reports standalone net loss of Rs 0.22 crore in the September 2024 quarter

    135 days ago

  • Parmax Pharma to conduct board meeting

    52 days ago

  • Parmax Pharma reports standalone net loss of Rs 0.22 crore in the September 2024 quarter

    135 days ago

  • Parmax Pharma to discuss results

    144 days ago

  • Parmax Pharma reports standalone net loss of Rs 0.39 crore in the December 2024 quarter

    44 days ago

  • Parmax Pharma to conduct board meeting

    52 days ago

  • Parmax Pharma reports standalone net loss of Rs 0.22 crore in the September 2024 quarter

    135 days ago

  • Parmax Pharma to discuss results

    144 days ago

  • Parmax Pharma reports standalone net loss of Rs 0.39 crore in the December 2024 quarter

    44 days ago

  • Parmax Pharma to conduct board meeting

    52 days ago

  • Parmax Pharma reports standalone net loss of Rs 0.22 crore in the September 2024 quarter

    135 days ago

  • Parmax Pharma to conduct board meeting

    52 days ago

  • Parmax Pharma reports standalone net loss of Rs 0.22 crore in the September 2024 quarter

    135 days ago

  • Parmax Pharma to discuss results

    144 days ago

1
2
3
4
5
6
7
8
9
10
1
2
3
4
Price vs Volume
JavaScript chart by amCharts 3.17.0
JavaScript chart by amCharts 3.17.0
JavaScript chart by amCharts 3.17.0Parmax PharmaSENSEX
JavaScript chart by amCharts 3.17.0Parmax Pharma Volume

Stock Trivia

  • Parmax Pharma Ltd has the Lowesr P/E ratio according to FY 202403 data among stocks in Pharmaceuticals Sector

  • Parmax Pharma Ltd has the Lowesr P/B ratio according to FY 202403 data among stocks in Pharmaceuticals Sector

  • Parmax Pharma Ltd has the Lowesr P/E ratio according to FY 202403 data among stocks in Pharmaceuticals Sector

  • Parmax Pharma Ltd has the Lowesr P/B ratio according to FY 202403 data among stocks in Pharmaceuticals Sector

  • Parmax Pharma Ltd has the Lowesr P/E ratio according to FY 202403 data among stocks in Pharmaceuticals Sector

  • Parmax Pharma Ltd has the Lowesr P/B ratio according to FY 202403 data among stocks in Pharmaceuticals Sector

1
2
3
4
Prev
1
2
Prev
Loading...

Peer Comparison on Risk - Return

Loading...
Loading...